Day: January 26, 2022

Panbela Initiates a Randomized, Double-Blind, Placebo-Controlled Study (ASPIRE) of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma

MINNEAPOLIS, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for...

Healthy Extracts Secures Two-Year Extension for Citrus Bergamot SuperFruit™ Exclusivity in U.S. and Canada, Supporting Continued Rapid Sales Ramp Up

Citrus Bergamot Healthy Extracts highest strength Citrus Bergamot SuperFruit has 47% BPF (bergamot-derived polyphenolic fraction) potency. LAS VEGAS, Jan. 26,...

error: Content is protected !!